Despite supportive earnings, DeepSeek shocked technology stocks. In the busiest week of the earnings season, tariffs and the ...

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

Sales of new U.S. single-family homes increased more than expected in December, further evidence that housing market activity ...

The pharmaceutical giant said for 2025 it anticipates sales growth in the mid-single-digit range at constant exchange rates, ...

Regarding its outlook, Stryker logged expects organic sales growth of 8% to 9% for 2025, and adjusted earnings of $13.45 to $13.70 a share, as it sees sustained levels of procedural volumes and strong ...

Q4 2024 Management View CEO Thomas Schinecker emphasized that 2024 was an "excellent year," with overall group sales growing ...

Net sales grew +12% (cc 1, +11% USD) with core operating income 1 up +22% (cc, +19% USD) Sales growth driven by continued st ...

Diageo's new finance chief Nik Jhangiani is under pressure to row back on the spirits giant's medium-term sales goals next ...

Swiss retail sales growth quickened in December to the highest level in four months amid faster rises in demand for food and non-food ...

Kimberly-Clark Corporation traded lower in premarket action on Tuesday after the household products company posted a mixed Q4 ...

Roche has reported a 7% increase in full-year 2024 sales at constant exchange rates (CER), reaching CHF 60.5bn ($66.9bn). The growth was driven by strong demand for new medicines, which offset ...

Scent & Care generated €347 million EBITDA in 2024, which was 25.4% higher than in the previous year (2023: €277 million 3 ), mainly due to profitable sales growth and the efficiency program initiated ...